AMPH
Amphastar Pharmaceuticals
$25.47
+$0.33 (+1.31%)Oct 26, 2026
Key metrics
The numbers that frame AMPH today
- Market cap
- $1.08B
- P/E (TTM)
- 15.1
- EV / FCF
- 10.1
- Gross margin
- 47.7%
- EV / Sales
- 2.1
- ROIC
- 9.4%
- Div yield
- 0%
- Debt / equity
- 0.9
- 52wk Low
- $16.65
- 52wk High
- $29.52
Growth
Revenue and earnings trend for AMPH
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AMPH
Is Amphastar Pharmaceuticals a good buy?
Yes. Amphastar Pharmaceuticals has excellent quality and excellent momentum. Both signals support the setup. Growth looks excellent, which supports the long-term business case. We think Amphastar Pharmaceuticals is selling at a low price.
What is the market capitalization of AMPH?
Amphastar Pharmaceuticals's market capitalization is $1.08B.
What is the P/E (TTM) ratio for AMPH stock?
Amphastar Pharmaceuticals's P/E (TTM) ratio is 15.1, based on trailing earnings.
What is the 52-week high for AMPH stock?
The 52-week high for Amphastar Pharmaceuticals is $29.52. The current close of $25.47 is 13.7% below that high.
What is the 52-week low for AMPH stock?
The 52-week low for Amphastar Pharmaceuticals is $16.65. The current close of $25.47 is 53% above that low.
Does AMPH stock pay dividends?
Amphastar Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AMPH?
Amphastar Pharmaceuticals's Debt / Equity ratio is 0.9.